<DOC>
	<DOCNO>NCT01553903</DOCNO>
	<brief_summary>This biomedical study interventional type include 29 patient 9 month : 8 month recruit 1 month follow . Patients hormone dependent breast cancer metastatic non-metastatic , indication hormonal therapy treatment ( tamoxifen anti-aromatase ) retain , enrol study . The main objective study evaluate feasibility determination Oxysterols ( CT , CE , OCDO ) patient population , initiation treatment ( ie , D0 D28 begin treatment ) .</brief_summary>
	<brief_title>Feasibility Study Determination Oxysterols Patients With Breast Cancer Receiving Hormonal Therapy With Tamoxifen Not</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Exemestane</mesh_term>
	<mesh_term>Anastrozole</mesh_term>
	<mesh_term>Letrozole</mesh_term>
	<mesh_term>Tamoxifen</mesh_term>
	<criteria>1 . Women 18 year old ( menopause ) . 2 . Women invasive breast cancer metastatic nonmetastatic , treatment tamoxifen antiaromatase retain . 3 . Cancer hormoneexpressing estrogen receptor ( ER ) / progesterone receptor ( PR ) ( ≥ 10 % tumor cell Technical HIC ) . 4 . Any previous hormonal therapy , stop progression , discontinue least 21 day prior study entry . 5. WHO ≤ 2 . 6 . Women childbearing age must use effective contraception duration study . 7 . Informed consent obtain sign specific procedure study . 8 . Patient member national insurance scheme . 1 . Patient breast cancer HER2 positive ( IHC / FISHCISH ) 2 . Patient already receive hormonal therapy patient stop hormonal therapy least 21 day . 3 . Patient receive chemotherapy / another target therapy ( hormonal therapy ) treatment breast cancer . 4 . Any medical psychiatric condition laboratory abnormality severe , acute chronic make inclusion patient study inappropriate opinion investigator . 5 . Patient unable follow procedure , visit , examination describe study . 6 . Pregnant woman nurse mother participate study . 7 . Patients legal guardianship .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Hormonal therapy</keyword>
	<keyword>Breast Cancer</keyword>
	<keyword>AEBS</keyword>
	<keyword>Oxysterols</keyword>
</DOC>